Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest asthma Stories

2013-06-19 12:26:30

DALLAS, June 19, 2013 /PRNewswire/ -- The Report "European Drug Delivery Technology Market (Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017" analyzes and studies the major market drivers, restraints and opportunities in the following Regions: - Germany - France - United Kingdom -...

2013-06-18 23:26:59

Inflamax Research Inc. Enters Strategic Partnership with Northern Air Environmental Technologies Inc. to Facilitate Engineering of Environment Control Systems for Inflamax Environmental Exposure Chambers Utilized in Allergy, Asthma, and Ocular Trials Mississauga, Ontario (PRWEB) June 18, 2013 Inflamax Research Inc., a full service CRO specializing in Proof of Concept and Phase I-IV clinical trials, announced today that they will have a strategic alliance with Northern Air Environmental...

2013-06-18 16:24:58

Funding announcement is PCORI's first in series targeting specific high-impact healthcare topics WASHINGTON, June 18, 2013 /PRNewswire-USNewswire/ -- Recognizing the persistent disparities in controlling asthma among African-American and Hispanic/Latino populations in the United States, the Patient-Centered Outcomes Research Institute (PCORI) today issued a call for research proposals to provide new information on ways to solve this problem. PCORI will invest up to $17 million in...

2013-06-17 16:21:11

CHAGRIN FALLS, Ohio, June 17, 2013 /PRNewswire/ -- With people spending, on average, about 93% of their time indoors, it's more important than ever to be conscious of Indoor Air Quality. Selecting flooring is about more than just choosing the right color and design-health should be a primary consideration. Tarkett, the leading provider of innovative and sustainable flooring is proud to offer healthy flooring options. (Photo: http://photos.prnewswire.com/prnh/20130617/CL33203 )...

2013-06-17 08:28:01

MISSISSAUGA, ON, June 17, 2013 /CNW/ - A second analysis of data from real-world study PATHOS, recently published in the British Medical Journal, shows that treatment of chronic obstructive pulmonary disease (COPD) patients with SYMBICORT(®) (budesonide/formoterol) was associated with a lower incidence of pneumonia and pneumonia related death, compared to treatment of COPD patients with ADVAIR(®) (fluticasone/salmeterol).(i) PATHOS is the largest real-world study to compare the...

2013-06-11 08:31:48

Company to highlight how latest release supports member engagement and medication adherence in booth #743 June 12-13 MADISON, Wis. and LAS VEGAS, June 11, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-?-lis), the FDA-cleared mobile health solution for asthma and COPD, will showcase its award-winning platform at America's Health Insurance Plans (AHIP) Institute, June 12-13 at the Wynn Las Vegas in booth #743. Asthmapolis is designed to help improve the care of people with asthma, advance...

2013-06-07 16:24:09

MADISON, Wis., June 7, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-?-lis), the FDA-cleared mobile health solution for asthma and COPD, today announces it received a second investment from the California HealthCare Foundation (CHCF). Asthmapolis is designed to improve the care of people with asthma and COPD, advance understanding of symptoms and triggers and help them achieve control of these diseases. The CHCF investment in Asthmapolis, which now totals $1,047,000, is directed at helping to...

2013-06-06 08:29:51

TEL AVIV, Israel, June 6, 2013 /PRNewswire/ -- Inspiro Medical [http://www.inspiromedical.com ], a portfolio company of The Trendlines Group, recently completed a successful clinical trial for InspiromaticTM, its innovative, breath-synchronized, active dry powder inhaler. The study, completed in May 2013 at Schneider Medical Center aimed to objectively assess, in a randomized, crossover, double blind study, the efficacy and safety profiles of formoterol (bronchodilator)...

2013-06-06 00:20:48

ZURICH, June 6, 2013 /PRNewswire/ -- Cytos Biotechnology Ltd ("Cytos") today announced that the Annual Shareholders' Meeting 2013 will take place on Friday, 28 June 2013, at 10 a.m. at Cytos' offices in Schlieren/Zurich (Switzerland). The invitation including the agenda is available for downloading at http://www.cytos.com/uploads/2013/Cytos_GV_Invitation_FINAL_2013.pdf About Cytos Biotechnology Ltd Cytos is a public biopharmaceutical company focused on the...

2013-06-04 08:30:15

SAN FRANCISCO, June 4, 2013 /PRNewswire/ -- Tunitas Therapeutics, Inc., a private company discovering and developing novel human fusion proteins for the treatment of asthma and other allergic diseases, has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Institute of Allergy and Infectious Disease (NIAID). The three-year, $3 million grant is aimed at advancing Tunitas' first clinical candidate, a member of the GE2 family, into preclinical development....


Latest asthma Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »